News | June 08, 2022
Halozyme announces commercial launch of testosterone undecanoate 'TLANDO'
TLANDO was approved by the U.S. Food and Drug Administration (FDA) on March 28, 2022.
TLANDO was approved by the U.S. Food and Drug Administration (FDA) on March 28, 2022.
If approved, ABBV-951 will offer patients the first continuous subcutaneous delivery of carbidopa/levodopa prodrugs
The latest certification endorses product for cold chain monitoring across 194 WHO member countries
Tirzepatide is primarily indicated for the treatment of T2D and is expected to receive its decision from the FDA in Q2 2022
The company exports mobile surgery equipment to over 100 countries from Pune
ASC22 (Envafolimab) is a subcutaneously administered single-domain antibody against PD-L1 and has the potential to restore virus-specific immune responses in patients with chronic viral infection
There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous
Evonik in association with Remondis has opened its first plant in India to ensure Zero Liquid Discharge. It is located at Dombivli in Western Maharashtra
Desidustat is currently approved only in India as OxemiaTM for patients with CKD induced anemia
The data driven fertility company helps increase the success rate of fertility treatments
Subscribe To Our Newsletter & Stay Updated
